sequestration

The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a new initiative which focuses on the myriad benefits of health and medical research, particularly as it relates to patient care. The initiative, titled From Hope to Cures , uses patient videos as well as statistical evidence and graphics to illustrate how the billions of dollars spent by pharmaceutical companies on research are extending and enriching the lives of millions of people. This new initiative represents a push for research, progress, and hope. There are numerous items on the initiative’€™s website including links to articles ranging from drug discovery and development to a study which predicts...
Dear Research Advocate, With Rep. Paul Ryan joining the Romney ticket, health is back on the national agenda. Partisan politics aside, this conversation is overdue, since health is indeed an issue that will make or bankrupt us. Research has always figured prominently in the wellbeing of Americans and America ’€“ research brought an end to the polio epidemic, which could have bankrupted the nation in the 1950s, and research is the only answer to the scourge of Alzheimer’€™s that threatens health, quality of life and our national checkbook today. And that is just a starting point for the conversation I hope you are having with everyone who wants to talk about the election. Take the...
Dear Research Advocate, American achievement continues to astound. This week we watched NASA’€™s Jet Propulsion Laboratory send one of the most advanced space exploration vehicles ever constructed to a planet hundreds of millions of miles away from Earth and elegantly deliver it to the planet’€™s surface. Mars today, why not a cure for our nation’€™s deadliest diseases tomorrow? As advocates, we cannot take no for answer when it comes to assuring we have the resources, policies and determination we need to defeat disease and disability. Why should we be reluctant to demand that this be a national priority? As Margaret Mead once said, ’€œNever doubt that a small group of thoughtful,...
Dear Research Advocate, Sequestration, the looming fiscal cliff, a dangerous House appropriations bill ’€“ all were addressed in our members-only call yesterday with Chairman John Porter. As Porter pointed out, we have to keep the big picture in mind, pushing for tax and entitlement reform as part of the larger ’€œfix,’€ AND, in the immediate, we have to cry foul about the House bill and sequestration. Right now, while Congress is still in session, we must flood their offices, and the Administration, with calls and e-mails. Take 30 seconds to send a message to your representatives to remind them that medical research should be among our nation’€™s highest priorities. And – as was...
Dear Research Advocate, What do sequencing and sequestration have in common, besides being mysterious words to most people? It’€™s pretty simple: We won’€™t have more of the former if the latter takes place. Why isn’€™t it a Sputnik moment to learn that there is more sequencing capacity at Beijing Genome Institute than we have total capacity in our country? And, to learn that the Chinese government is subsidizing the cost of sequencing so that it is fast becoming the go-to place for industry and academia worldwide? It’€™s time for advocates to talk this up so that policy makers will once again plus-up research as a U.S. priority. Jeffrey Zients, the Acting Director of the White House Office...
A graphic from a recent amfAR report shows the potential loss of life because of across-the-board cuts, or sequestration. Research!America’s report on sequestration detailed the devastating impact that the sequester, or across-the-board cuts that are scheduled to take place in 2013, will have on federally funded research to improve health. Now, a recent report by amfAR trains the focus of sequestration on global health. Just as we found, amfAR reaches the same conclusion: Sequestration isn’t worth the cost. The cuts would save $689 million ’€” or 0.63% of the required deficit reduction for FY13. And at what cost? HIV/AIDS treatment for 273,000 fewer people, potentially leading to 62,000...

Pages

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America